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IDH3 mediates apoptosis of alveolar epithelial cells
type 2 due to mitochondrial Ca2+ uptake during
hypocapnia
Martina Kiefmann*,1, Sascha Tank1, Paula Keller1, Christian Börnchen1, Jan L Rinnenthal2, Marc-Oliver Tritt1, Leonie Schulte-Uentrop1,
Cynthia Olotu1, Alwin E Goetz1 and Rainer Kiefmann1
In adult respiratory distress syndrome (ARDS) pulmonary perfusion failure increases physiologic dead-space (VD/VT) correlating
with mortality. High VD/VT results in alveolar hypocapnia, which has been demonstrated to cause edema formation, atelectasis, and
surfactant depletion, evoked, at least in part, by apoptosis of alveolar epithelial cells (AEC). However, the mechanism underlying
the hypocapnia-induced AEC apoptosis is unknown. Here, using fluorescent live-cell imaging of cultured AEC type 2 we could
show that in terms of CO2 sensing the tricarboxylic acid cycle enzyme isocitrate dehydrogenase (IDH) 3 seems to be an important
player because hypocapnia resulted independently from pH in an elevation of IDH3 activity and subsequently in an increase of
NADH, the substrate of the respiratory chain. As a consequence, the mitochondrial transmembrane potential (ΔΨ) rose causing a
Ca2+ shift from cytosol into mitochondria, whereas the IDH3 knockdown inhibited these responses. Furthermore, the hypocapnia-
induced mitochondrial Ca2+ uptake resulted in reactive oxygen species (ROS) production, and both the mitochondrial Ca2+ uptake
and ROS production induced apoptosis. Accordingly, we provide evidence that in AEC type 2 hypocapnia induces elevation of
IDH3 activity leading to apoptosis. This finding might give new insight into the pathogenesis of ARDS and may help to develop
novel strategies to reduce tissue injury in ARDS.
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The adult respiratory distress syndrome (ARDS) is a typical
complication of ventilated intensive care patients with an
incidence of almost 10% and a mortality rate of ~ 40%. There
are many predisposing factors known, including pneumonia,
sepsis, or trauma. Inflammation, alveolar-capillary barrier
dysfunction, development of lung edema, and formation
of atelectasis typically in the dorsal regions of both lungs
are the hallmarks of ARDS. Accordingly, opening of atelectatic
lung regions, avoiding their re-collapse by applying a
positive end-expiratory pressure, reducing the tidal volume
during ventilation, and, if necessary, extracorporeal oxy-
genation and CO2 removal are the treatment approaches
in ARDS.
Although the pathogenesis of ARDS has been extensively
studied over the last decades, a causal therapy has not been
found yet. During the last years it became clear that in both the
ARDS and its experimental equivalent, the acute lung injury,
intravascular coagulation, and perfusion disorders lead to an
increase of the physiologic dead-space fraction (VD/VT), which
is associated with increased mortality.1 In contrast to the
CO2 accumulation in the arterial blood, the CO2 concentration
in alveoli may drop, especially in lung regions with high VD/VT.
It has been shown that alveolar hypocapnia may contribute
to tissue injury, including depletion of surfactant, which
is produced by alveolar epithelial cells (AEC) type 2 and
normally opposes the alveolar-collapsing tendency by
lowering the air–liquid surface tension. Furthermore, reduced
secretion of surfactant is commonly seen in ARDS patients
and is associated with worse outcomes especially in critically-
ill patients (which has been excellently reviewed by J Laffey
et al.2–6). Thus, the alveolar hypocapnia-induced AEC type 2
damage seems to be likely in ARDS. However, the underlying
mechanism has not been elucidated yet.
Apoptosis of AEC potentially has an important role in ARDS.
Decreased size and condensation of the chromatin of AEC
type 2 have been shown early in human ARDS.7 Moreover,
caspase-cleaved cytokeratin-18, a marker for epithelial cell
apoptosis, increases in bronchoalveolar lavage fluids during
ARDS.8
Several pathways of apoptosis induction are known, also in
the context of ARDS. One important trigger for apoptosis is
the mitochondrial Ca2+ overload, especially in combination
with increased mitochondrial production of reactive oxygen
species (ROS).9 Importantly, mitochondrial Ca2+ uptake
and ROS production can mutually be dependent. The driving
force for mitochondrial Ca2+ uptake is the negative transmem-
brane potential gradient (ΔΨ) across the mitochondrial inner
membrane.10,11 There are reports that ΔΨ can be increased by
stimulation of the respiratory chain with its substrate NADH,
which is produced in the tricarboxylic acid (TCA) cycle by the
enzymes isocytrate dehydrogenase (IDH) 3 and α-ketogluta-
rate dehydrogenase12–15 together with CO2.
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According to the law of mass action the accumulation of the
product may inhibit, whereas a rapid clearance of the product
may accelerate its enzymatic reaction rate. We therefore
hypothesize that a decrease of the alveolar partial pressure
of CO2 (pCO2), which occurs in lung regions with high
VD/VT, increases IDH3 activity, NADH production, and thus
ΔΨ in AEC.
Using real-time fluorescence microscopy of AEC type 2 we
could identify that mitochondrial IDH3 is a key player in CO2
sensing. Accordingly, under hypocapnic conditions the result-
ing increase of IDH3 activity elicits an increase of ΔΨ and
subsequently a shift of Ca2+ from the cytosol into mitochon-
dria. In consequence, the hypocapnia-induced mitochondrial
Ca2+ uptake leads to elevation of mitochondrial ROS produc-
tion, and thus apoptosis. The understanding of this context
may help to develop strategies to reduce AEC type 2 injury,
including formation of atelectasis, in ARDS patients with
elevated VD/VT. Furthermore, the opening of atelectasis, a
central element of ADRS therapies, should be re-evaluated in
non-perfused lung regions to prevent hypocapnic conditions
and thus apoptosis of AEC.
Results
Hypocapnia increases IDH3 activity and thus NADH
production. Using extracts of primary isolated AEC type 2
we were able to show that hypocapnia at constant pH of
7.4 did not induce a detectible increase of IDH3 activity
(Figure 1a). We assumed that the IDH3 product NADH, which
was measured for IDH3 activity determination, was oxidized
by the complex 1 of the respiratory chain before its colori-
metric assay detection. Therefore, we inhibited the complex 1
with rotenone. Under these conditions, hypocapnia-induced
NADH production was detectable. Furthermore, the respec-
tive NADH production rate was higher in comparison with
rotenone alone (Figure 1a). Importantly, the used biochemical
assay was specific for the mitochondrial isoenzyme IDH3,
because the added co-substrate NAD+ does not react with
the non-mitochondrial IDH isoforms 1 and 2.
In addition, using biexponential 2-photon fluorescence
lifetime imaging microscopy (FLIM) we could show that
lifetimes for free (τfree) or bound (τbound) NAD(P)H were
438±47 or 2156± 295 ps, respectively (Supplementary
Figure 1a). In total, 91.8±0.5% of the detected NAD(P)H
was bound (Supplementary Figure 1b ). According to Blacker
et al.16 τbound measurements can be used to discriminate
between NADH and NADPH. These authors predicted that
τbound values for NADH and NADPH were 1.5 and 4.4 ns,
respectively. Hence, the measured τbound values of ~ 2
indicated that under both normo- and hypocapnic conditions
primary isolated AEC type 2 produced rather NADH than
NADPH (Figures 1b and c). We could detect the NAD(P)H
fluorescence predominantly in small granules located around
the non-fluorescent nucleus, which are ascribed to mito-
chondria,17 (Figure 1a Supplementary Figure 1b and d)
indicating that under our experimental condition the
main NADH production site is the TCA cycle. In line with
the enzymatic IDH3 activity assay results, hypocapnia alone
did not change NAD(P)H fluorescence in comparison with
normocapnic conditions (Figures 1e and f). However, after
rotenone pretreatment NAD(P)H fluorescence steadily
increased and further increased after additional hypocapnia
(Figures 1d–f) in comparison with hypocapnia alone. Because
after rotenone alone or in combinationwith hypocapniaNAD(P)H
fluorescence increased, whereas after both interventions τbound
stayed stable at 2 ns we assume that under both conditions,
rather NADH than NADPH was produced (Figures 1b and c).
All experiments were conducted at constant pH of 7.4.
In accordance with the FLIM experiments on primary
isolated AEC type 2, in rotenone-treated A549 cells the NAD
Figure 1 IDH3 activity and NADH concentration in AEC type 2. (a) Group data of IDH3 activity in primary isolated AEC type 2 measured every 5 min under normocapnic
(pCO2: 40 mm Hg) or hypocapnic (pCO2: 0 mm Hg) conditions without or with rotenone (1 μM), respectively, at constant extracellular pH of 7.4. 50 000 cells/well. Mean±S.E.,
‡Po0.05 versus pCO2: 0 mm Hg (hypocapnia) alone. Each measurement of a single experiment was repeated twice. In total, 2–10 cells were analyzed per picture. Each
experiment was repeated six times. (b) Color-coded images and (c) quantification of changes in τbound in primary isolated AEC type 2 under normocapnic (pCO2: 40 mm Hg)
conditions alone or in combination with rotenone or after hypocapnia (pCO2: 0 mm Hg) in combination with rotenone. Mean± S.E., repeated four times. (d) Images of primary
isolated AEC type 2 show the pseudocolor-coded NAD(P)H. Upper panel, left group: left picture – normocapnic condition (baseline), right picture – normocapnic condition (control
intervention); upper panel, right group: left picture – normocapnic condition (baseline), right picture – hypocapnic condition alone (intervention); lower panel, left group: left picture –
normocapnic condition (baseline), right picture – normocapnic condition+rotenonre (intervention); lower panel, right group: left picture – normocapnic condition (baseline),
right picture – hypocapnic condition+rotenone (intervention). pH was constant at 7.4. A total of 2–10 cells were analyzed per picture. Experiments were repeated four times.
(e)Δ percentage change of the NAD(P)H fluorescence in primary isolated AEC type 2 under normocapnic baseline conditions, after rotenone (1 μM) or vehicle application, and
again under normo- or hypocapnic conditions, as indicated. Black line represents normocapnic condition, red line represents hypocapnic condition. Experiments were conducted
at constant pH of 7.4 throughout. Mean±S.E., †Po0.05 versus rotenone at pCO2 of 40 mm Hg (normocapnia). In total, 2–10 cells were analyzed per image. Experiments were
repeated four times. (f) Rate of NAD(P)H fluorescence change during baseline conditions, hypocapnia alone, normocapnia in combination with rotenone or hypocapnia in
combination with rotenone at constant pH of 7.4, as indicated. Mean± S.E., *Po0.05 versus pCO2 of 40 mm Hg alone (control), †Po0.05 versus rotenone at pCO2 of
40 mm Hg (normocapnia). In total, 3–10 cells were analyzed per image. Experiments were repeated four times. (g) Images showing NADH auto-fluorescence (measured at ex.:
360 nm and em: 510 nm) of native or IDH3-siRNA-treated A549 cells superfused with normocapnic (pCO2: 40 mm Hg) or hypocapnic (pCO2: 0 mm Hg) buffer without or with
rotenone, as indicated. (h) Tracing of the percentage change of the NADH auto-fluorescence in native or IDH3-siRNA-treated A549 cells superfused with normo- or hypocapnic
buffer, as indicated, at constant pH of 7.4. Rotenone (1 μM) was applicated as indicated. (i) Group data of maximal NADH auto-fluorescence response 10 min following rotenone
(1 μM) under normocapnic conditions or 10 min following additionally switching to hypocapnic conditions in native or IDH3-siRNA-treated A549 cells in comparison with
normocapnic baseline conditions. Experiments were performed at constant extracellular pH of 7.4. Mean± S.E., #Po0.05 versus baseline (pCO2: 40 mm Hg). †Po0.05 versus
rotenone at pCO2 of 40 mm Hg in native cells,
$Po0.05 versus rotenone at pCO2 of 0 mm Hg in native cells. In total, 4–11 cells were analyzed per picture. Experiments were
repeated six times. (j) (Left) Gels show RT-PCR products for IDH3- and GAPDH-mRNA in native (lane 2 and 3), in IDH3-siRNA- (lane 4 and 5), and scRNA-treated (lane 6 and 7)
A549 cells. Lane 1 and 8: molecular weight ladder. (Right) Group data of relative IDH3-mRNA expression, *Po0.05 versus scRNA (control), n= 4–5 each. (k) Western blot show
IDH3 protein in native (lane 2 and 3), in scRNA- (lane 4 and 5), and IDH3-siRNA-treated (lane 6 and 7) A549 cells. Lane 1 and 8: molecular weight ladder
IDH3 senses CO2
M Kiefmann et al
2
Cell Death and Disease
(P)H auto-fluorescence increase was higher under hypo- than
normocapnic conditions (Figures 1g–i). Importantly, the NAD
(P)H auto-fluorescence in A549 cells was confined to
mitochondrial localization, indicating again the mitochondrial
origin of the NAD(P)H production (Figure 1g). As auto-fluores-
cence is not specific to NADH we further measured NADH
concentration in A549 cells extracts by using an enzymatic
assay. We revealed that NADH concentration 15 min upon
onset of hypocapnia was only slightly increased in comparison
to normocapnia (Supplementary Figure 2). However, after
rotenone hypocapnia doubled the NADH concentration
within 30 min (Supplementary Figure 2), indicating again that
without rotenone treatment the NADH produced under
hypocapnia is immediately consumed by the complex 1 of
the respiratory chain.
To further elucidate the specificity of IDH3 in the hypo-
capnia-induced NADH production process we downregulated
this enzyme in A549 cells. Themitochondrial IDH3 knockdown
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blocked the hypocapnia-induced increase of the NAD(P)H
auto-fluorescence (Figures 1g–i). The IDH3 knockdown was
verified on mRNA and protein level (Figures 1j and k,
respectively). Taken together, we conclude first that, indepen-
dent from pH, hypocapnia increases the mitochondrial IDH3
activity and thus the NADH production rate and second that,
directly after its synthesis, NADH is totally consumed by the
complex 1 of the respiratory chain.
The hypocapnia-induced acceleration of IDH3 activity
and thus NADH production subsequently increases mito-
chondrial ΔΨ. We next determined whether the hypocapnia-
induced increase of IDH3 activity, NADH production rate and
subsequent respiratory chain NADH consumption elevated
ΔΨ. The characterization of the primary isolated AEC type 2
was revealed by the detection of LTG-stained lamellar bodies
(Figure 2a). In these cells, hypocapnia at constant pH
of 7.4 led to an increase of the ratio between the mito-
chondrial and cytosolic tetramethylrhodamine methyl ester
(TMRM) fluorescence intensity equivalent for an increase
of ΔΨ (Figures 2b,c and e). Under normocapnic conditions,
rotenone decreased, as expected, the TMRM ratio (Figures
2d and e) verifying the correctness of the method. In these
rotenone-treated cells, hypocapnia did not increase the
TMRM ratio and thus ΔΨ (Figures 2d and e). All these
results could be reproduced in A549 cells (Figures 2f–i).
Figure 1 Continued
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Figure 2 ΔΨ in alveolar epithelial cells in vitro. (a) Images show primary isolated AEC type 2. For ΔΨ quantification cells were loaded with TMRM. For characterization
identical cells were additionally stained with the AEC type 2-specific lamellar body marker LTG (middle). (b) Images showing fluorescence of TMRM-loaded primary isolated AEC
type 2 superfused with normocapnic (pCO2: 40 mm Hg) or hypocapnic (pCO2: 0 mm Hg) buffer without or with rotenone (1 μM), as indicated. (c, d) Tracing of the ratio between
mitochondrial and cytosolic TMRM fluorescence intensity in primary isolated AEC type 2 superfused with normo- or hypocapnic buffer without or with rotenone (1 μM), as
indicated, at constant pH of 7.4. (e) Group data of maximal TMRM ratio response 15 min after switching from normocapnic (pCO2: 40 mm Hg) baseline to hypocapnic (pCO2:
0 mm Hg) conditions in primary isolated AEC type 2 at constant extracellular pH of 7.4. Mean± S.E., #Po0.05 versus baseline (pCO2: 40 mm Hg), ‡Po0.05 versus pCO2:
0 mm Hg alone. In total, 3–9 cells were analyzed per picture. Experiments were repeated 4–6 times. (f) Images show rhod-2 fluorescence of native, scRNA, or IDH3-siRNA-
treated A549 cells under normocapnic conditions alone or in combination with rotenone and under hypocapnic condition alone or in combination with rotenone, as indicated. (g)
Tracing of the ratio between mitochondrial and cytosolic TMRM fluorescence intensity of native, scRNA- or IDH3-siRNA-treated A549 cells superfused with normo- or hypocapnic
buffer, as indicated, at constant pH of 7.4. (h) Tracing of the ratio between mitochondrial and cytosolic TMRM fluorescence intensity of native A549 cells superfused with
normocapnic buffer alone (pCO2: 40 mm Hg) or in combination with rotenone, or superfused with hypocapnic buffer (pCO2: 0 mm Hg) in combination with rotenone, as indicated,
at constant pH of 7.4. (i) Group data of maximal TMRM ratio response 15 min after switching from normocapnic (pCO2: 40 mm Hg) baseline condition to hypocapnia alone, to
normocapnia plus rotenone, or to hypocapnia (pCO2: 0 mm Hg) plus rotenone in native, scRNA-, IDH3-siRNA-, or MCU-siRNA-treated A549 cells at constant extracellular pH of
7.4, as indicated. Mean± S.E., #Po0.05 versus baseline (pCO2: 40 mm Hg), ‡Po0.05 versus pCO2: 0 mm Hg alone in native or scRNA-treated A549 cells. In total, 4–12 cells
were analyzed per picture. Experiments were repeated 4–6 times. (j) (Left) Gels show RT-PCR products for MCU- and UBC-mRNA in native (lane 1–4), in scRNA- (lane 5–8), and
MCU-siRNA-treated (lane 9–12) A549 cells. Lane 13: no template control, lane 14: negative control, lane 15 molecular weight ladder. (Right) Group data of relative MCU-mRNA
expression, *Po0.05 versus scRNA (control), n= 4 each. (k) Western blot show MCU protein in native (lane 1 and 4), in scRNA- (lane 2 and 5), and MCU-siRNA-treated (lane 3
and 6) A549 cells. Lane 7: molecular weight ladder
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Figure 2 Continued
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Furthermore, in these cells the IDH3 knockdown inhibited
the hypocapnia-induced increase of ΔΨ (Figures 2f, g and i).
Summarizing, the hypocapnia-induced increase of IDH3
activity, NADH production rate, and subsequent respiratory
chain NADH consumption caused an elevation of mitochon-
drial ΔΨ.
As mentioned before, ΔΨ can be the driving force for
mitochondrial Ca2+ uptake but it is also well known that
mitochondrial Ca2+ regulates IDH3 and respiratory chain
activity. Accordingly, we conclude that mitochondrial Ca2+ is
not responsible for the observed ΔΨ changes. We could
demonstrate that the silencing of the mitochondrial Ca2+
uniporter (MCU) did not inhibit the hypocapnia-induced ΔΨ
increase (Figure 2i). The MCU knockdown was verified on
mRNA and protein level (Figures 2j and k, respectively).
Hypocapnia induces mitochondrial Ca2+ uptake from the
cytosol. We next determined in primary isolated AEC
type 2 the hypocapnia-induced mitochondrial Ca2+ uptake.
The characterization of these cells was again revealed by the
detection of LTG-stained lamellar bodies (Figure 3a). Switch-
ing from normo- to hypocapnic conditions induced a rhod-2
fluorescence intensification, equivalent to an increase of the
mitochondrial Ca2+ concentration [Ca2+]mito (Figures 3b,c,f).
This response was completely reversible after switching back
to normocapnic buffer. All experiments were performed at a
constant extracellular pH of 7.4. The mitochondrial localiza-
tion of the rhod-2 fluorescence was proofed by its co-
localization with the mitochondrial marker MitoTracker green
(MTG) (data not shown) and by the observation that in AEC
type 2 the rhod-2 fluorescence decreases, as expected, after
inhibition of the mitochondrial electron chain by rotenone
(Figures 3d and f). Furthermore, in primary isolated AEC type
2 cells the hypocapnia-induced increase of the rhod-2
fluorescence intensity could be blocked by either rotenone
or the MCU inhibitor ruthenium red (Figures 3d–f). In line with
these findings hypocapnia induced an increase of rhod-2
fluorescence in A549 cells at constant pH of 7.4 (Figures
3g,h,j). In addition, the hypocapnia-induced mitochondrial
Ca2+ uptake could be verified by FRET (Supplementary
Figure 3A–C). The measurement of mitochondrial Ca2+ with
FRET was validated by ATP or rotenone as it is well known
that ATP increases and rotenone decreases [Ca2+]mito.
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Moreover, in A549 cells the MCU silencing prevented the
hypocapnia-induced increase of rhod-2 fluorescence inten-
sity (Figures 3i and j). We therefore assumed that hypocapnia
shifts Ca2+ from the cytosol into mitochondria. Importantly,
IDH3 silencing inhibited the hypocapnia-induced increase of
rhod-2 fluorescence intensity indicating that the elevated
IDH3 activity and ΔΨ were responsible for the hypocapnia-
induced mitochondrial Ca2+ uptake (Figures 3i and j).
To further test if mitochondria incorporate Ca2+ from the
cytosolic compartment we measured cytosolic Ca2+ concen-
tration [Ca2+]cyt in primary isolated AEC type 2. A switch of
pCO2 from 40 to 0 mm Hg decreased [Ca
2+]cyt by 25± 5%
versus baseline conditions within 10 min in a reversible
manner (Figures 4a–c, e). Exposing primary isolated cells to
hypocapnic conditions for 30 min revealed that the hypo-
capnia-induced [Ca2+]cyt decrease is transient (Supplemen-
tary figure 4). Interestingly, switching back to normocapnic
conditions causes an overshooting increase of [Ca2+]cyt
assuming that cells compensate the hypocapnia-induced
[Ca2+]cyt decrease by mechanisms, as e.g., decrease of
cell membrane Ca2+ pump activity. The pretreatment of AEC
type 2 cells with ruthenium red or rotenone inhibited the
hypocapnia-induced [Ca2+]cyt decrease (Figures 4d and e). In
accordance to these findings, in A549 cells hypocapnia
reduced [Ca2+]cyt 20±2%, which was inhibited by rotenone
(Figures 4f,g,i). In addition, both the MCU and IDH3 silencing
inhibited the hypocapnia-induced decrease of [Ca2+]cyt
(Figure 4h).
We could demonstrate that in native A549 cells ATP
alone caused an increase of [Ca2+]cyt, which was comparable
to that after ATP in combination with rotenone. Further, the
ATP response in native A549 cells did not differ from
the ATP responses in scRNA- or IDH3-siRNA-treated
cells. This indicates that both rotenone and IDH3 knock-
down did not affect cell viability at least in terms of receptor-
mediated Ca2+-signaling cascades (Supplementary figure 5).
Furthermore, we were also interested whether pH may play
a role in Ca2+ response induced by hypocapnia. Without
additional buffering, the removing of the dissolved CO2
increased the pH of the superfusion buffer from 7.4 to 7.8.
Under these conditions hypocapnia induced a similar reduc-
tion of [Ca2+]cyt in A549 cells as at constant extracellular pH
of 7.4 revealed by buffering (Supplementary figure 6A). In
contrast, an alkalosis of 7.8 under normocapnic conditions did
not induce an alteration of [Ca2+]cyt (Supplementary figure 6A).
Furthermore, the cytosolic pH was not affected in unbuffered
cells (Supplementary figure 6B). We therefore conclude
that the hypocapnia-induced [Ca2+]cyt responses were pH
independent.
Since Ca2+ can be shifted directly from the endoplasmatic
reticulum (ER) to mitochondria, we measured Ca2+ in
the ER [Ca2+]ER. In contrast to [Ca
2+]cyt and [Ca
2+]mito,
hypocapnia did not change [Ca2+]ER (Supplementary figure
7A–C). However, this ratio was clearly elevated after ATP
application indicating the correctness of the method
(Supplementary figure 7A–C). Taken these results together,
we conclude that hypocapnia and thus acceleration of IDH3
activity induces a Ca2+ shift from the cytosol to the
mitochondria, whereas, the ER seems to have a minor role
in this scenario.
Both, the hypocapnia-induced increase of [Ca2+]mito and
associated mitochondrial ROS production evoke apop-
tosis of AEC type 2. To investigate whether hypocapnia
causes mitochondrial ROS production in primary isolated
AEC type 2 cells we used the fluorescent MitoSOX Red
mitochondrial superoxide indicator for live-cell imaging. We
could show that under hypocapnia the ROS production,
expressed as delta increase of the dye, was enhanced in
comparison with normocapnia (Figure 5). To evaluate the
respiratory chain as potential source of ROS we used
rotenone under both normo- and hypercapnia. Rotenone
almost diminished the hypocapnia-induced delta increase,
whereas rontenone with normocapnia did not change ROS
production in comparison with normocapnia alone (Figure 5).
In addition, ROS production was also inhibited after
ruthenium red incubation, which blocked the mitochondrial
IDH3 senses CO2
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Figure 3 [Ca2+]mito in AEC type 2. (a) Images show primary isolated AEC type 2. For characterization cells were stained with the cytosolic dye fura 2 and with the AEC type
2-specific lamellar body marker LTG (middle). (b) For measurement of [Ca2+]mito, AEC type 2 cells were loaded with rhod-2. Images showing fluorescence of rhod-2-loaded
primary isolated AEC type 2 under normocapnic (pCO2: 40 mm Hg) baseline condition and after hypocapnia (pCO2: 0 mm Hg) alone or in combination with rotenone (1 μM), as
indicated. (c–e) Tracing of rhod-2 fluorescence in primary isolated AEC type 2 superfused with normo- or hypocapnic buffer alone or in combination rotenone (1 μM) or ruthenium
red (10 μM), as indicated. Experiments were performed at constant extracellular pH of 7.4, respectively. (f) Group data of maximal rhod-2 fluorescence responses in primary
isolated AEC type 2 10 min following switching from normocapnic (pCO2: 40 mm Hg) baseline to hypocapnic (pCO2: 0 mm Hg) conditions without or with rotenone (1 μM) or
ruthenium red (10 μM) pretreatment, as indicated. Experiments were performed at constant extracellular pH of 7.4 throughout. Mean±S.E., #Po0.05 versus baseline (pCO2:
40 mm Hg), ‡Po0.05 versus pCO2 of 0 mm Hg alone. In total, 5–10 cells were analyzed per picture. Experiments were repeated 6 times. (g) Images showing fluorescence of
rhod-2-loaded A549 cells under normocapnic (pCO2: 40 mm Hg) baseline or hypocapnic (pCO2: 0 mm Hg) conditions. (h, i) Tracings of rhod-2 fluorescence in native, scRNA-,
IDH3-siRNA-, or MCU-siRNA-treated A549 cells. Cells were superfused with normo- or hypocapnic buffer, as indicated. Experiments were performed at constant extracellular pH
of 7.4. (j) Group data of maximal rhod-2 fluorescence responses in native, scRNA-, IDH3-siRNA-, or MCU-siRNA-treated A549 cells 10 min after switching from normocapnic
(pCO2: 40 mm Hg) baseline to hypocapnic (pCO2: 0 mm Hg) conditions. Experiments were performed at constant extracellular pH of 7.4 throughout. Mean±S.E.,
#Po0.05
versus baseline (pCO2: 40 mm Hg),
‡Po0.05 versus pCO2: 0 mm Hg alone in native or scRNA-transfected cells. 5–10 cells were analyzed per picture. Experiments were
repeated 6 times
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calcium uniporter and subsequently the mitochondrial
Ca2+-uptake. Mitochondrial Ca2+ and ROS are potential
trigger for apoptosis. Therefore, we used a CellEvent
Caspase-3/7 fluorogenic substrate to detect apoptotic cells
upon hypercapnia in a live-cell image setting. As depicted in
Figure 6a, the percent of apoptotic cells increased from
20.1±5.9 under normocapnia to 48.8±6.6 under hypercap-
nia. Treatment with rotenone or ruthenium red prevented the
initiation of apoptosis (23.8±8.1% apoptotic cells and
16.4±4.6% apoptotic cells, respectively) (Figure 6a). In
order to validate these results we measured as an additional
apoptosis marker the expression of cleaved poly-(ADP-
ribose) polymerase (PARP) in primary isolated AECs type 2.
Western blot analysis of this protein revealed that only cells
cultured under hypocapnic conditions express cleaved PARP,
which was inhibited by rotenone or ruthenium red (Figure 6b).
Under normocapnic condition alone or in combination with
rotenone or ruthenium red cleaved PARP was not detectable
(Figure 6b).
Discussion
We provide evidence that in AEC type 2 hypocapnia increases
IDH3 activity and NADH production, ΔΨ, [Ca2+]mito, and
mitochondrial ROS concentration, which in turn induces
apoptosis (Figure 7).
For the first time, at least to our knowledge, we were able to
measure an increase of the IDH3 activity in primary isolated
AEC type 2 in response to hypocapnia. In this context, we
have to critically emphasize that we could not see any
increase of NADH concentration in AEC type 2 subjected
solely to hypocapnia. Instead, after rotenone we could
measure a steady rise of NADH concentration, which could
further be increased in combination with hypocapnia. We
concluded that NADH produced under hypocapnic conditions
is immediately consumed by complex 1 and can thus not been
detected. Inhibition of complex I however blocked the NADH
consumption and after this intervention the hypocapnia-
induced NADH production was detectable.
Figure 3 Continued
IDH3 senses CO2
M Kiefmann et al
9
Cell Death and Disease
Figure 4 [Ca2+]cyt, in alveolar epithelial cells in vitro. (a) Images show primary isolated AEC type 2. For [Ca
2+]cyt measurement cells were loaded with fura 2 (left). For
characterization cells were additionally stained with LTG (middle), a marker for type 2-specific lamellar bodies. (b) Images show the 340:380 ratio in pseudocolor of the identical
fura 2-loaded primary isolated AEC type 2 under normocapnic (pCO2: 40 mm Hg) baseline or hypocapnic (pCO2: 0 mm Hg) conditions at constant pH of 7.4. (c) Tracing of [Ca
2+]
from an identical epithelial cell superfused with normo- (pCO2: 40 mm Hg) or hypocapnic (pCO2: 0 mm Hg) buffer, as indicated. (d) Tracings of [Ca
2+] from an identical epithelial
cell superfused with normo- (pCO2: 40 mm Hg) or hypocapnic (pCO2: 0 mm Hg) buffer, as indicated. Cells were pretreated with rotenone or ruthenium red, as indicated. (e) Bars
show group data of maximal [Ca2+]cyt response in primary isolated AEC type 2 15 min after intervention. Cells were pretreated with vehicle, rotenone (1 μM), or ruthenium red
(10 μM), as indicated. Under baseline conditions cells were superfused with buffer at following conditions: pCO2: 40 mm Hg and pH 7.4 for each group. Buffer conditions after
intervention were: pCO2: 0 mm Hg and pH 7.4 for each group. Mean± S.E.,
#Po0.05 versus baseline (pCO2 of 40 mm Hg), ‡ Po0.05 versus pCO2 of 0 mm Hg alone. In total,
3–9 cells were analyzed per picture. Experiments were repeated six times each. (f) Images show the pseudocolor-coded 340:380 ratio for fura 2-loaded A549 cells under
normocapnic (pCO2: 40 mm Hg) baseline or hypocapnic (pCO2: 0 mm Hg) conditions at constant pH of 7.4. (g) Tracing of [Ca
2+]cyt from an identical epithelial cell superfused with
normo- (pCO2: 40 mm Hg) or hypocapnic (pCO2: 0 mm Hg) buffer, as indicated. pH was constant at 7.4. (h) Tracings of [Ca
2+]cyt from an identical epithelial cell superfused with
normo- (pCO2: 40 mm Hg) or hypocapnic (pCO2: 0 mm Hg) buffer, as indicated. Cells were untreated or treated with scRNA, IDH3-siRNA, or MCU-siRNA, as indicated. (i) Group
data of maximal [Ca2+]cyt responses 10 min following switching from normocapnic (pCO2: 40 mm Hg) baseline to hypocapnic conditions (pCO2: 0 mm Hg) at constant
extracellular pH of 7.4 in native, scRNA-, IDH3-siRNA-, or MCU-siRNA-treated A549 cells. Mean± S.E., #Po0.05 versus baseline (pCO2: 40 mm Hg), ‡Po0.05 versus pCO2:
0 mm Hg in native or scRNA-treated A549 cells. In total, 3–10 cells were analyzed per picture. Experiments were repeated 6 times
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The dependency of the respiratory chain activity fromNADH
has been demonstrated by Kuznetsov et al.19 Hence, as a
consequence of hypocapnia-induced elevation of NADH
production, ΔΨ and thus the driving force for the mitochondrial
Ca2+ uptake increased. This hypothesis was supported by the
IDH3 knockdown. However, the IDH3 knockdown did not
completely blocked the hypocapnia-induced NADH and ΔΨ
responses. Reason for this result could be either that the IDH
knockdown was not efficient enough or, more importantly,
other mechanisms for the hypocapnia-induced NADH and ΔΨ
responses are involved. Hypothetically, low pCO2 could also
act on mitochondrial Ca2+ handling, e.g., on increase of
mitochondrial Ca2+ influx or decrease of mitochondrial Ca2+
efflux. In this context another aspect has to be discussed:
because IDH3 is one of the first enzymes of the TCA cycle and
therefore upstream of all other TCA cycle enzymes, e.g., the
CO2 producing alpha-ketoglutarate dehydrogenase, the IDH3
knockdown would affect these enzyme activities, which could
also contribute to the hypocapnia-induced changes of in
NADH and ΔΨ. This might be the reason why the IDH
knockdown was highly efficient. In contrast, it could be
assumed that the IDH3 knockdown would affect the overall
flux through the TCA cycle. Unfortunately, we cannot exclude
this hypothesis. However, we measured cytosolic Ca2+
responses to the purinergic receptor agonist ATP in IDH3-
siRNA-treated AEC and the revealed Ca2+ responses were
comparable to native and even to rotenone-treated AEC
indicating that, at least, G-protein coupled receptor Ca2+
signaling is intact.
To determine whether the hypocapnia-induced increase of
NADH and ΔΨ elicits a Ca2+ shift into mitochondria from the
cytosol we measured both [Ca2+]mito and [Ca
2+]cyt. Accord-
ingly, we could demonstrate on both primary isolated AEC
type 2 and A549 cells that hypocapnia was accompanied not
only by a [Ca2+]mito increase but also by a [Ca
2+]cyt decrease.
In order to differentiate whether the Ca2+ responses in AEC
Figure 4 Continued
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type 2 were CO2 rather than pH mediated, we additionally
measured [Ca2+]cyt primarily in A549 cells under several pH
conditions and found that in AEC type 2 [Ca2+]cyt response to
CO2 is independent from pH.
Moreover, we could show that the hypocapnia-induced
[Ca2+]cyt response was inhibited by MCU knockdown or
pharmacological blockade of the MCU with ruthenium red
confirming a Ca2+ shift from the cytosol into mitochondria.
From these experiments we further conclude that the driving
force for the mitochondrial Ca2+ uptake came from the
mitochondria and not from the cytosol since in response to
hypocapnia [Ca2+]cyt rather de- than increased. According to
the literature, the [Ca2+]mito increase can also be evoked by a
Ca2+ shift from the ER directly into mitochondria. In our
scenario this pathway seems to be unlikely because [Ca2+]ER
was unaffected by hypocapnia. However, we cannot exclude
the possibility that the ER was synchronously re-filled with
cytosolic Ca2+, whereas Ca2+ was shifted from the ER into
mitochondria. It has also been described that mitochondria
can uptake Ca2+ from the extracellular space. Indeed, this
possibility, at least in part, cannot be excluded by our
experiments, too.
The inhibition of the CO2-induced Ca
2+ shift by rotenone
and the unaffected [Ca2+]ER suggests that the driving force for
the mitochondrial Ca2+ uptake was an increase of the
respiratory chain activity and hence ΔΨ rather than ER. This
hypothesis was confirmed by our finding that the fluorescence
of TMRM, which accumulates in mitochondria in a potential-
dependent manner, was enhanced in both primary isolated
AEC type 2 and in A549 cells under hypo- compared with
normocapnic conditions. Addition of rotenone revealed, as
expected, a quick decrease of the TMRM fluorescence
indicating that the respiratory chain activity is the important
determinant of ΔΨ. Further, hypocapnia induced an increase
of the respiratory chain substrate NADH and the knockdown of
the NADH-producing IDH3 inhibited NADH, ΔΨ, [Ca2+]mito,
and [Ca2+]cyto response under low CO2 levels.
Taken together, we suggested that CO2, a by-product of
IDH3, inhibits IDH3 activity via a negative feedback loop.
Under hypocapnic conditions, this inhibitory effect of CO2 on
the IDH3 activity is reduced which subsequently increases
NADH production and in turn ΔΨ which, at least in part, lead to
a Ca2+ shift into mitochondria.
The hypocapnia-induced mitochondrial Ca2+ uptake was
associated with AEC type 2 apoptosis. Ca2+ enters mitochon-
dria via the Ca2+ uniporter. As its pharmacological inhibition by
ruthenium red prevented both Ca2+ uptake and apoptosis we
conclude that the hypocapnia-induced Ca2+ uptake was, at
least in part, responsible for the apoptosis of AEC type 2. We
can only speculate about the underlying mechanism. Increase
in [Ca2+]mito has been shown to induce apoptosis by
alterations in mitochondrial membrane permeability, formation
of the permeability transition pore, cytochrome c release, and
activation of caspase-9 and -3 and disruption of ΔΨ. We could
demonstrate that immediately after onset of hypocapnia ΔΨ
increases. However, we have no data on ΔΨ 24 h after
hypocapnia because TMRMmeasurements are useful only for
a short time period. There are reports that especially Ca2+
coming from the ER might be one trigger for apoptosis. As
stated above, this way of apoptosis induction might be
Figure 6 (a) Group data of caspase positive primary isolated AEC type 24 h
following normocapnia (pCO2: 40 mm Hg), hypocapnia (pCO2: 0 mm Hg) alone or in
combination with ruthenium red (10 μM) or rotenone (1 μM). Experiments were
performed at constant extracellular pH of 7.4. Mean±S.E., #Po0.05 versus
baseline. *Po0.05 vs pCO2: 40 mm Hg alone (control), ‡Po0.05 versus pCO2:
0 mm Hg alone. Repeated four times. (b) Gels show PARP cleavage protein in native
primary isolated AEC typ 2 (except lane 9). Lane 1 and 10: molecular weight ladder,
lane 2: normocapnia, lane 3: hypocapnia, lane 4: normocapnia+rotenone, lane 5:
normocapnia+ruthenium red, lane 6 hypocapnia+rotenone, lane 7: hypocapnia
+ruthenium red, lane 8: staurosporine as positive control, lane 9: Hela cells
+staurosporine as positive control
Figure 5 Group data of Mitosox fluorescence increase versus normocapnic
(pCO2: 40 mm Hg) baseline conditions in primary isolated AEC type 2, 20 min
following normocapnia (pCO2: 40 mm Hg) alone, hypocapnia (pCO2: 0 mm Hg)
alone or in combination with ruthenium red (10 μM) or rotenone (1 μM), or
normocapnia in combination with rotenone (1 μM), as indicated. Experiments were
performed at constant extracellular pH of 7.4. Mean±S.E., #Po0.05 versus
baseline (pCO2: 40 mm Hg),
‡Po0.05 versus pCO2: 0 mm Hg alone, *Po0.05
versus pCO2: 40 mm Hg alone (control). Repeated four times
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possible in our scenario but we were not able to proof this
hypothesis.
We could show that hypocapnia is associated with
mitochondrial ROS production. As this response could be
inhibited by rotenone we conclude that the hypocapnia-
induced ROS was produced in the respiratory chain. In
addition, the mitochondrial ROS production could be inhibited
by ruthenium red. We therefore conclude that, at least in part,
the hypocapnia-induced mitochondrial Ca2+ uptake was
responsible for the ROS response. Although the Ca2+-dependent
mitochondrial ROS production is well established we cannot
give any proof for the mechanism of the Ca2+-dependent
ROS production. Theoretically, it could be the case that the
hypocapnia-induced increase of NADH production results
in a higher amount of ubisemiquinone on complex III of
the respiratory chain. This might statistically increases the
probability that the electron will instead be donated to O2,
generating superoxide. Furthermore, a reverse electron
transport may occur under hypocapnia and be responsible
for the hypocapnia-induced ROS production. Moreover, we
cannot differentiate whether apoptosis was evoked directly by
Ca2+, ROS, or both of them.
In summary, we identify a novel CO2-sensing mechanism of
AEC type 2 in which the mitochondrial TCA enzyme IDH3 has
a key role. Under hypocapnic conditions, IDH3 activity and
thus NADH production increases, which subsequently
induces mitochondrial Ca2+ uptake and ROS production
leading to apoptosis. We propose that this mechanism plays
an important role in the pathogenesis of ARDS because
alveolar hypocapnia may occur in lung regions with high
VD/VT. According to our results one could consider a novel
ARDS therapy, namely CO2 inhalation in order to prevent
hypocapnia-induced apoptosis of AECs and tissue injury
in ARDS.
Materials and Methods
Animals. Male Sprague-Dawley rats (350 g) were purchased from Charles River
(Sulzfeld, Germany). After review and approval by the local ethics committee and
the government of Hamburg, all animals were treated humanely in accordance with
'principles of laboratory animal care' (NIH Publication No. 86-23, revised 1985) as
well as with the German legislation on protection of laboratory animals.
Materials. Fura 2-AM, LysoTracker green (LTG), MTG, rhod-2, 2´, 7`-bis-(2-
carboxylmethyl)-5-(and 6-) carboxyfluorescin-AM and TMRM were purchased from
Molecular probes (Thermo Fisher Scientific, Waltham, MS, USA). Both rotenone
and ruthenium red were purchased from Sigma-Aldrich (St. Louis, MO, USA).
Vehicle for dyes and other agents was HBSS buffer (150 mmol/l Na+, 5 mmol/l K+,
1.0 mmol/l Ca2+, 1 mmol/l Mg2+, and 20 mmol/l HEPES at pH 7.4). All esterified
fluorescent probes were prepared as stock solutions in dimethylsulfoxide.
Primary AEC type 2 isolation and cell culture. Isolation and culture of
AEC type 2 from adult male Sprague-Dawley rats according to procedures
described previously.20,21 In brief, after injection of 100 mg/kg ketamine and 20 mg/
kg xylazinum (rompun), the lungs were surgically exposed and perfused with
3 × 10 ml F-12 K medium (ATCC, Manassas, VA, USA) supplemented with 25 mM
HEPES (Sigma-Aldrich) to remove blood. After multiple lavages (5 × 10 ml) via the
cannulated trachea with 5 mM ethylenediaminetetraacetic acid (EDTA, Sigma-
Aldrich) and 5 mM ethylene glycol-bis (ß-aminoehtylether)-N,N’,N’-tetraacetic acid
(Sigma-Aldrich) in a phosphate-buffered salt solution the lungs were removed from
the body. Upon instillation of 20 ml warm F-12K medium (ATCC) enriched with
50 mM HEPES and 4.5 units/ml elastase Grade II (Worthington, Lakewood NJ,
USA) the lungs were incubated at 37 °C for 30 min. After dissection of the large
airways the lungs were added to 10 ml F-12K medium containing 25 mM HEPES,
20% fetal bovine serum (FBS, Biochrom AG, Berlin, Germany), and 100 μg/ml
DNAse (Typ IV, Sigma-Aldrich) quickly minced and incubated at 4 °C for 10 min.
Then the solution was mixed by end-over end-rotation for 4 min and filtered
successively through cotton gauze (1, 2, and 4 ply, respectively) following filtration
through nylon mesh (100 and 40 μm, BD Falcon, Corning, NY, USA). Upon
centrifugation of the cell suspension at 150 × g for 10 min and resuspension in 20 ml
warm DMEM (Biochrom AG) the cells were applied to plates covered with rat
immunoglobulin (Ig) G (Sigma-Aldrich) for 1 h at 37 °C. The nonadherent cells were
removed, collected in sterile tube, twice centrifuged at 150 × g for 10 min and
resuspended in 3 ml of culture medium (DMEM with 10% FBS, 1% penicillin/
streptomycin and 10 ng/ml keratinocyte growth factor (Sigma-Aldrich)). After
determination of cell count and viability, cells were plated on collagen-treated
coverslips and incubated at 37 °C and 5% CO2.
Human lung carcinoma A549 cells were grown in F-12K Medium (ATCC) with 10%
FBS, 10 000 U/ml penicillin and 10 000 μg/ml streptomycin (Biochrom AG). A549 is
an alveolar epithelial cell line with type 2 cell characteristics including production of
surfactant proteins. It has been widely used as a model to study the response of AEC
in several conditions.22,23
Conventional fluorescent real-time cell imaging. For fluorescent
imaging, a coverslip with fluorophore-loaded primary isolated AEC type 2 or A549
cells was mounted in an imaging/perfusion chamber on the stage of a conventional
epifluorescence microscope (Olympus, Hamburg, Germany). The imaging chamber
was perfused continuously with warm HEPES buffer (37 °C).
Fluorophores were excited by a mercury arc lamp illumination directed through
appropriate interference filters and filter sets (Semrock, Rochester, NY, USA).
Figure 7 (a) IDH3 catalyzes the oxidative decarboxylation of isocitrate, producing
α-ketoglutarate and CO2 while converting NAD
+ to NADH (I). Because IDH3 activity is
negatively regulated by its product CO2 we conclude that under hypocapnic
conditions IDH3 activity (II) and thus NADH production (III) rises. (b) Proposed
sequence of events underlying Ca2+-dependent CO2-sensing mechanism. Alveolar
perfusion failure in ventilated lung regions, equivalent to a VD/VT increase, leads to
alveolar hypocapnia (I). Alveolar hypocapnia elevates IDH3 activity via a feedback
mechanism (II). In turn, NADH (III) production and ΔΨ (IV) increases leading to a
calcium shift from cytosol into the mitochondrium (V). Further, the hypocapnia-
induced mitochondrial Ca2+ uptake leads to mitochondrial ROS production (VI).
Finally, the mitochondrial Ca2+ uptake and/or ROS production results in apoptosis
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Fluorophore exposure was controlled by a filter wheel (Sutter Lambda 10-C, Sutter
Instrument Co). The fluorescence emission was collected using an objective lens
(40 × water immersion, numerical aperture 0.8, Zeiss, Oberkochen, Germany) and
captured with a charge-coupled device camera (Photometrics Coolsnap HQ2,
Tuscan, AZ, USA).
[Ca2+]cyt determination. For [Ca
2+]cyt measurements, cells were loaded for 45 min
with 10 μM fura 2-AM in physiological solution containing 0.02% pluronic. The cells
were excited at 340 and 380 nm. The fluorescence emissions at 510 nm were
recorded and [Ca2+]cyt was calculated from a computer-generated 340:380 emissions
ratio based on a dissociation constant of 224 nmol/l and appropriate calibration
parameters.24
Fluorescence images were recorded under normo- or hypocapnic conditions in
combination with an extracellular pH of 7.4 or 7.8 at 10 s intervals.
[Ca2+]mito determinations. For [Ca
2+]mito measurements, cells were loaded
with rhod-2-AM for 15 min followed by a Ringer´s flush. To improve the specifity of
[Ca2+]mito measurement mitochondria were additionally localized by the fluorophore
MTG, which binds specifically to the inner mitochondrial membrane.25 The
wavelength for excitation was 560 nm, whereas monitoring the emission at 590 nm.
Mitochondrial membrane potential measurement: For mitochondrial
membrane potential assessment, primary isolated AEC type 2 or A549 cells were
loaded with TMRM. This indicator dye is a lipophilic cation accumulated by
mitochondria in proportion to the electrical potential across their inner membrane
(Δψ).26 The wavelength for excitation was 560 nm while monitoring the emission at
590 nm. Addition of the mitochondrial depolarizer FCCP (50 nM) resulted in a rapid
loss of the mitochondrial TMRM fluorescence.
Mitochondrial NADH production: NADH concentration was quantified by
measuring its auto-fluorescence intensity. Primary isolated AEC type 2 or A549
were excitated with 360 nm while monitoring the emission at 510 nm. For
determining the mitochondrial production of NADH, its auto-fluorescence was
co-localized with the mitochondria-specific marker MTG.
Determination of mitochondrial ROS Production: Mitochondrial ROS
production was measured using MitoSOX Red (Thermo Fisher Scientific). Primary
isolated AEC type 2 were stained with 10 μM MitoSOX Red and 10 μM MTG
(staining of mitochondria) for 10 min at 37 °C. Upon washing with normocapia
buffer, cells were then imaged with a conventional epifluorescence microscopy
(Olympus) in normo- and hypocapnia puffer, respectively. Changes in the
fluorescence intensity of MitoSOX Red were measured at 550 nm excitation and
600 nm emission wavelengths. In an additional set of experiments we preincubated
the cell with 1 μM rotenone to inhibit Complex I of the electron chain and/or 10 μM
ruthenium red to inhibit the MCU. As a positive control we used Antimycin AA
(2 μg/ml).
Determination of Caspase-3/7-positive cells: We used the Cell Event
Caspase-3/7 Green Detection Reagent (Thermo Fisher Scientific) according to the
manufacture’s instruction to determine apoptotic cells. In brief, upon incubation with
normo- und hypocapnia puffer for 30 min at 37 °C primary isolated AEC type 2 were
stained 24 h later with the caspase-3/7 reagent (10 μM) and counterstained with the
nuclei dye Hoechst 33342 (0.5 μg/ml). Cells were then image with a conventional
epifluorescence microscopy (Olympus) and caspase-3/7-positive cells were counted
in four independent fields per well.
2-Photon and FLIM. To determine changes of NADH / NAD(P)H during
inhibition of complex I and/or under hypocapnia treatment, FLIM was performed on
a single-beam 2-photon microscope setup described elsewhere.27 In brief, the
excitation wavelength of the pulsed Ti:Sa Laser (MaiTai, Spectra Physiscs) was
750 nm and sent through a water-dipping lens (20 × , NA 0.95, WD 2 mm –
Olympus) to the lung surface. Emission photons passed a band-pass filter
(475/47 nm) and were finally detected at the Ultra-sensitive-port by a 16-channel
time-correlated single photon counter, with a maximum rate of 78 MHz (LaVision
Biotec, Bielefeld, Germany). Evaluation of the multi-exponential fluorescence signal
was performed by the self-developed software RINIFLIM programmed in Matlab
(MathWorks). For evaluation, Levenberg-Marquardt algorithms were used.
IDH3 activity. The NAD+-dependent IDH3 activity was determined using the
commercial available IDH activity assay kit according to the manufactures protocol
(Sigma-Aldrich). In brief, the IDH3 activity in cell extracts was measured using the
substrate isocitrate and the cofactor NAD+ in an enzyme reaction, which results in a
colorimetric (450 nm) product proportional to NADH concentration. The enzyme
activity was calculated according to the standard curve. One unit of IDH3 is the
amount that will generate 1.0 μmol NADH per minute at pH 8.0 at 37 °C.
IDH3 and MCU knockdown. A549 cells were transfected with 10 nM stealth
siRNA of IDH3 (Thermo Fisher Scientific) and/or 10 nM siRNA of MCU (Quiagen,
Hilden Germany) and scrambled siRNA (Thermo Fisher Scientific and Quiagen) by
using Lipofectamine RNAIMAX (Thermo Fisher Scientific) according to the
manufacturer’s protocol. In brief, siRNA was diluted in 500 μl Opti-MEM I medium
(Quiagen) without serum in a well of the tissue culture plate. Lipofectamine
RNAiMAX was added to each well containing the diluted siRNA. Cells were diluted
in complete growth medium without antibodies so that the cell density after 24 h
would be 30–50% confluent after plating.
Real-time quantitative RT-PCR for IDH3 and MCU knockdown
analysis. Total RNA was isolated using the RNeasy Kit (Quiagen). A total of 2 μg
of RNA were used for cDNA synthesis using the Maxima First Strand cDNA
Synthesis Kit (Thermo Fischer Scientific) according to the manufacturer´s
instructions. qRT-PCR was performed with gene- and species-specific primers.
cDNA template was amplified using the QuantiNova SYBR GreenPCR Kit
(Quiagen) on a Rotor-Gene (Quiagen) according to the manufacture’s protocol.
Quantitative analysis of data were performed by using the deltadeltaCT method.
Western blot for IDH3 and MCU knockdown analysis. For
immunoblotting, cells were washed twice with PBS and then scraped into RIPA
buffer (Sigma-Aldrich) supplemented with the protease inhibitor cocktail complete
Mini EDTA-free (Roche Diagnostics, Mannheim, Germany). Upon incubation on ice
for 30 min lysed cells were centrifuged at 12 000 × g for 20 min (4 °C). The
supernatants with the cytoplasmatic protein were collected, and protein
concentrations were determined by using the bicinchoninic acid (BCA protein
assay kit, Thermo Fisher Scientific), assay according to the manufacturer’s
instructions. A total of 20 μg samples were reduced in sample buffer (NuPAGE
sample buffer, Thermo Fisher Scientific) plus reducing agent (NuPAGE sample
reducing agent, Invitrogen) at 95 °C for 5 min and run on a 4–12% Bis-Tris
polyacrylamid gel (NuPage, Thermo Fisher Scientific) and transferred to
nitrocellulose filters (Thermo Fisher Scientific). The filters were blocked for 1 h at
room temperature in blocking puffer (PBS plus 0.1% Tween 20 containing 5% milk
powder and/or 5% bovine serum albumin (BSA)) with agitation. After application to
the polyclonal rabbit IDH3A antibody (1:800, GenWay Biotech Inc., San Diego, CA,
USA) or to the monoclonal rabbit MCU antibody (1:1000, Cell Signaling Technology,
Danvers, MA, USA) overnight at 4 °C, the filters were exposed to an ECL
horseradish peroxidise-conjugated donkey anti-rabbit IgG (1:10 000 and/or
1:20 000), GE Healthcare, Little Chalfont, UK) for 1 h at room temperature with
agitation. After washing with washing puffer (PBS plus 0.1% Tween 20), the filters
were developed with the ECL Plus Western Blotting Detection Reagents (GE
Healthcare) according the manufacture’s protocol. For molecular weight standards,
we used a MagicMark XP protein ladder (Thermo Fisher Scientific).
Western blot analysis for PARP cleavage. Upon incubation with normo-
und hypocapnia puffer for 3 h at 37 °C primary isolated AEC type 2 were collected
24 h later and prepared for immunoblotting as described in the section 'Western blot
IDH3 and MCU knockdown analysis’. After gelelectrophoresis and immunoblotting,
filter were blocked for 1 h at room temperature in blocking puffer (PBS plus 0.1%
Tween 20 containing 5% BSA) with agitation. Upon application of the monoclonal
rabbit Anti-cleaved-PARP antibody (1:500, Abcam, Cambridge, UK) overnight at
4 °C, the filters were exposed to an ECL horseradish peroxidise-conjugated goat
anti-rabbit IgG (1:5000, Jackson ImmunlResearch Labaroties, Inc, West Grove, PA,
USA) for 1 h at room temperature with agitation. After washing with washing puffer
(PBS plus 0.1% Tween 20), the filters were developed with the ECL Plus Western
Blotting Detection Reagents (GE Healthcare) according the manufacture’s protocol.
For molecular weight standards, we used a MagicMark XP protein ladder (Thermo
Fisher Scientific). As a positive control, we used staurosporine (1 μM) treated cells.
Statistics. All data are represented as means±S.E. Statistical data analysis
was performed using SigmaStat (Systat Software, Chicago, IL, USA). Comparisons
between two groups were tested using RankSumTest. Comparisons between more
groups were tested by ANOVA on ranks followed by a pairwise multiple comparison.
IDH3 senses CO2
M Kiefmann et al
14
Cell Death and Disease
Repeated measurements were tested using the Mann–Whitney Rank Sum Test.
Statistical significance was accepted at Po0.05.
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